-
Q4 EPS Estimate for Halozyme Therapeutics Boosted by Analyst
Source: Buzz FX / 22 Feb 2025 08:56:17 America/New_York
Q4 EPS Estimate for Halozyme Therapeutics Boosted by Analyst Written by MarketBeat February 22, 2025 Share Link copied to clipboard. Halozyme Therapeutics, Inc. ( NASDAQ:HALO - Free Report ) - Stock analysts at Leerink Partnrs lifted their
Read more...